← Open Payments lookup

SYED-MOHAMMED JAFRI: Open Payments

NPI 1801027644 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$80,302 in 73 payments from 9 companies in 2025. Trend: 2023 $91,894 · 2024 $47,910 · 2025 $80,302

Consulting: $37,247Speaker / faculty: $34,180Travel & lodging: $5,467Speaker / faculty: $2,170Food & beverage: $1,237
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.26$34,303
Gilead Sciences, Inc.25$20,172
VectivBio AG4$12,457
ABBVIE INC.13$11,052
Intercept Pharmaceuticals, Inc.1$2,170
Madrigal Pharmaceuticals1$71
Boehringer Ingelheim Pharmaceuticals, Inc.1$29
Dendreon Pharmaceuticals LLC1$29
Novo Nordisk Inc1$17

Products named: GATTEX, Epclusa, MAVYRET, Livdelzi, OCALIVA, REZDIFFRA, PROVENGE.

Industry payments across MI — which companies pay providers there.